Milk Thistle (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (08/17/2018)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Laboratory/Animal/Preclinical Studies

This section was extensively revised.

Human/Clinical Studies

Revised outcome findings from the studies on advanced hepatocellular carcinoma and hepatic dysfunction, viral hepatitis B, alcohol-induced cirrhosis, and primary biliary cirrhosis in Table 3.

This summary is written and maintained by the PDQ Integrative, Alternative, and Complementary Therapies Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Databasepages.

< Previous section
Summary of the Evidence for Milk Thistle

Next section >
About This PDQ Summary